Melissa M. Lai

Melissa M. Lai

Auto-generated profile, based on publicly available information

Melissa M. Lai

Grantley Stable Neonatal Unit (GSNU), Royal Brisbane and Women’s Hospital, Herston, Brisbane, Australia

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Clinical Neurophysiology
Verified
Journal Article
Closed access
MAMd. Abdul Awal
Md. Abdul Awal
MLMelissa M. Lai
Melissa M. Lai
Ghasem AzemiGhasem Azemi
Ghasem Azemi
BBBoualem Boashash
Boualem Boashash
PCPaul Colditz
Paul Colditz

16 September 2015 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
JGJoanne M. George
Joanne M. George
RBRoslyn Boyd
Roslyn Boyd
PCPaul Colditz
Paul Colditz
SRStephen E. Rose
Stephen E. Rose
KPKerstin Pannek
Kerstin Pannek
SBSasaka E. Bandaranayake
Sasaka E. Bandaranayake
More than 50 percent of all infants born very preterm will experience significant motor and cognitive impairment. Provision of early intervention is dependent upon accurate, early identification of infants at risk of adverse outcomes. Magnetic resonance imaging at term equivalent age combined with General Movements assessment at 12 weeks corrected age is currently the most accurate method for early prediction of cerebral palsy at 12 months corrected age. To date no studies have compared the use of earlier magnetic resonance imaging combined with neuromotor and neurobehavioural assessments (at 30 weeks postmenstrual age) to predict later motor and neurodevelopmental outcomes including cerebral palsy (at 12–24 months corrected age). This study aims to investigate i) the relationship between earlier brain imaging and neuromotor/neurobehavioural assessments at 30 and 40 weeks postmenstrual age, and ii) their ability to predict motor and neurodevelopmental outcomes at 3 and 12 months corrected age. This prospective cohort study will recruit 80 preterm infants born ≤30 week’s gestation and a reference group of 20 healthy term born infants from the Royal Brisbane & Women’s Hospital in Brisbane, Australia. Infants will undergo brain magnetic resonance imaging at approximately 30 and 40 weeks postmenstrual age to develop our understanding of very early brain structure at 30 weeks and maturation that occurs between 30 and 40 weeks postmenstrual age. A combination of neurological (Hammersmith Neonatal Neurologic Examination), neuromotor (General Movements, Test of Infant Motor Performance), neurobehavioural (NICU Network Neurobehavioural Scale, Premie-Neuro) and visual assessments will be performed at 30 and 40 weeks postmenstrual age to improve our understanding of the relationship between brain structure and function. These data will be compared to motor assessments at 12 weeks corrected age and motor and neurodevelopmental outcomes at 12 months corrected age (neurological assessment by paediatrician, Bayley scales of Infant and Toddler Development, Alberta Infant Motor Scale, Neurosensory Motor Developmental Assessment) to differentiate atypical development (including cerebral palsy and/or motor delay). Earlier identification of those very preterm infants at risk of adverse neurodevelopmental and motor outcomes provides an additional period for intervention to optimise outcomes. Australian New Zealand Clinical Trials Registry ACTRN12613000280707 . Registered 8 March 2013.

11 August 2014 in Journal of Paediatrics and Child Health
Verified
Journal Article
Closed access
PDF file
MCMichael J Colditz
Michael J Colditz
MLMelissa M Lai
Melissa M Lai
DCDavid W Cartwright
David W Cartwright
PCPaul Colditz
Paul Colditz

27 August 2016 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
MLMelissa M. Lai
Melissa M. Lai
GDGiulia D’aCunto
Giulia D’aCunto
Andrea GuzzettaAndrea Guzzetta
Andrea Guzzetta
RBRoslyn Boyd
Roslyn Boyd
SRStephen E. Rose
Stephen E. Rose
PCPaul Colditz
Paul Colditz
Preterm infants follow an altered neurodevelopmental trajectory compared to their term born peers as a result of the influence of early birth, and the altered environment. Infant massage in the preterm infant has shown positive effects on weight gain and reduced length of hospital stay. There is however, limited current evidence of improved neurodevelopment or improved attachment, maternal mood or anxiety. The aim of this study is to investigate the effects of infant massage performed by the mother in very preterm (VPT) infants. Effects on the infant will be assessed at the electrophysiological, neuroradiological and clinical levels. Effects on maternal mood, anxiety and mother-infant attachment will also be measured. A randomised controlled trial to investigate the effect of massage therapy in VPT infants. Sixty VPT infants, born at 28 to 32 weeks and 6 days gestational age, who are stable, off supplemental oxygen therapy and have normal cranial ultrasounds will be recruited and randomised to an intervention (infant massage) group or a control (standard care) group. Ten healthy term born infants will be recruited as a reference comparison group. The intervention group will receive standardised massage therapy administered by the mother from recruitment, until term equivalent age (TEA). The control group will receive care as usual (CAU). Infants and their mothers will be assessed at baseline, TEA, 12 months and 24 months corrected age (CA), with a battery of clinical, neuroimaging and electrophysiological measures, as well as structured questionnaires, psychoanalytic observations and neurodevelopmental assessments. Optimising preterm infant neurodevelopment is a key aim of neonatal research, which could substantially improve long-term outcomes and reduce the socio-economic impact of VPT birth. This study has the potential to give insights into the mother-baby relationship and any positive effects of infant massage on neurodevelopment. An early intervention such as massage that is relatively easy to administer and could alter the trajectory of preterm infant brain development, holds potential to improve neurodevelopmental outcomes in this vulnerable population. Australian New Zealand Clinical Trials Registry: ACTRN12612000335897 . Date registered: 22/3/2012.

1 December 2018 in Early Human Development
Verified
Journal Article
Closed access
AKAnnice H.T. Kong
Annice H.T. Kong
MLMelissa M. Lai
Melissa M. Lai
SFSimon Finnigan
Simon Finnigan
Robert WareRobert Ware
Robert Ware
RBRoslyn N. Boyd
Roslyn N. Boyd
PCPaul B. Colditz
Paul B. Colditz

23 February 2022 in Pediatric Research
Verified
Journal Article
Open access
PDF file
NSNathan J. Stevenson
Nathan J. Stevenson
MLMelissa M. Lai
Melissa M. Lai
HSHava E. Starkman
Hava E. Starkman
PCPaul Colditz
Paul Colditz
JWJulie Wixey
Julie Wixey
Foetal growth restriction (FGR) and being born small for gestational age (SGA) are associated with neurodevelopmental delay. Early diagnosis of neurological damage is difficult in FGR and SGA neonates. Electroencephalography (EEG) has the potential as a tool for the assessment of brain development in FGR/SGA neonates. In this review, we analyse the evidence base on the use of EEG for the assessment of neonates with FGR or SGA. We found consistent findings that FGR/SGA is associated with measurable changes in the EEG that present immediately after birth and persist into childhood. Early manifestations of FGR/SGA in the EEG include changes in spectral power, symmetry/synchrony, sleep–wake cycling, and the continuity of EEG amplitude. Later manifestations of FGR/SGA into infancy and early childhood include changes in spectral power, sleep architecture, and EEG amplitude. FGR/SGA infants had poorer neurodevelopmental outcomes than appropriate for gestational age controls. The EEG has the potential to identify FGR/SGA infants and assess the functional correlates of neurological damage. Impact: FGR/SGA neonates have significantly different EEG activity compared to AGA neonates. EEG differences persist into childhood and are associated with adverse neurodevelopmental outcomes. EEG has the potential for early identification of brain impairment in FGR/SGA neonates.